Using Protozoan Surface Proteins for Effective Oral Vaccination.

Administration, Oral Humans Membrane Proteins / immunology Protozoan Proteins / immunology Vaccination / trends Vaccine Potency Vaccines / immunology World Health Organization
antimicrobial resistance antitumor therapy infectious diseases oral vaccines protozoan proteins virus-like particles

Journal

Trends in parasitology
ISSN: 1471-5007
Titre abrégé: Trends Parasitol
Pays: England
ID NLM: 100966034

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 06 2019
revised: 01 07 2019
accepted: 09 07 2019
pubmed: 1 8 2019
medline: 25 11 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

The Global Vaccine Action Plan of the World Health Organization (WHO) calls for nonsyringe delivery mechanisms, thermostable vaccines, and new bioprocessing technologies as priority research areas. Here we discuss the use of protozoan surface proteins to develop a safe, stable, and efficient versatile oral vaccine platform.

Identifiants

DOI: 10.1016/j.pt.2019.07.004 PMID: 31362858
pubmed: 31362858
pii: S1471-4922(19)30169-2
doi: 10.1016/j.pt.2019.07.004
pii:
doi:

Substances chimiques

Membrane Proteins 0
Protozoan Proteins 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-10

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Lucía Lara Rupil (LL)

Centro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas (CIDIE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)/Universidad Católica de Córdoba (UCC), Córdoba, Argentina; Facultad de Ciencias de la Salud, Universidad Católica de Córdoba (UCC), Córdoba, Argentina.

Marianela Del Carmen Serradell (MDC)

Centro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas (CIDIE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)/Universidad Católica de Córdoba (UCC), Córdoba, Argentina; Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.

Hugo Daniel Luján (HD)

Centro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas (CIDIE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)/Universidad Católica de Córdoba (UCC), Córdoba, Argentina; Facultad de Ciencias de la Salud, Universidad Católica de Córdoba (UCC), Córdoba, Argentina. Electronic address: hlujan@cidie.ucc.edu.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Administration par voie orale › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de protozoaire › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Phénomènes du système immunitaire › Relation dose-réponse (immunologie) › Efficacité du vaccin › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Using Protozoan Surface Proteins for Effective...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Organisation mondiale de la santé › Using Protozoan Surface Proteins for Effective...